Search
  • BioExcel

Efficacy of Hydroxychloroquine in Patients with COVID-19: Results of a Randomized Clinical Trial

by Juan Lama



Aims: Studies have indicated that chloroquine (CQ) shows antagonism against COVID-19 in vitro. However, evidence regarding its effects in patients is limited. This study aims to evaluate the efficacy of hydroxychloroquine (HCQ) in the treatment of patients with COVID-19.


Main methods:From February 4 to February 28, 2020, 62 patients suffering from COVID-19 were diagnosed and admitted to Renmin Hospital of Wuhan University. All participants were randomized in a parallel-group trial, 31 patients were assigned to receive an additional 5-day HCQ (400 mg/d) treatment, Time to clinical recovery (TTCR), clinical characteristics, and radiological results were assessed at baseline and 5 days after treatment to evaluate the effect of HCQ. 


Read FINDINGS


#infectious disease  #Hydroxychloroquine#COVID-19  #Clinical Trial  #BioExcel Consulting

7 views0 comments